Further Evaluation of Potential Caps in Part D Shows Promise for Beneficiary Impact
April 14, 2022
A recently released report from the Urban Institute shows that a firm limit on out-of-pocket (OOP) Part D costs, like
Help protect Medicare’s future—support our 2025 Annual Benefit on Oct 28!
Prescription Drugs
The Inflation Reduction Act (IRA) takes important steps to reduce drug prices and lower costs for people with Medicare and the program, such as capping beneficiary out-of-pocket spending; requiring Medicare to negotiate drug prices; and expanding eligibility for the full Part D low-income subsidy (LIS). We support an implementation process that centers the beneficiary experience and look forward to building upon these landmark policies.
New KFF Report Examines Beneficiary Exposure to Part B Drug Costs
March 17, 2022
A new brief from the Kaiser Family Foundation (KFF) examines the often extreme cost liability that Part B covered drugs—typically,
Drug Prices Already Rising in 2022
March 10, 2022
A new analysis from the AARP Public Policy Institute finds drug companies have increased prices for many brand name Part
Medicare Rights Supports Important Proposals for Medicare Advantage and Part D Plans
March 10, 2022
This week, Medicare Rights submitted comments on a proposed rule that would make some important changes to Medicare Advantage (MA)
Medicare Rights Joins 90 Organizations Urging Senate to Pass Drug Pricing Reforms
February 10, 2022
This week, over 90 advocacy and other organizations sent a letter to U.S. Senators, urging them to pass the drug
Letter to Senators Urging Drug Pricing Reform
February 9, 2022
Medicare Rights joined over 90 groups to urge US Senators to pass drug pricing reforms through reconciliation.
Proposed Rule Might Reduce Out-of-Pocket Drug Costs for Some People with Medicare
January 13, 2022
Last week, the Centers for Medicare & Medicaid Services (CMS) released a new proposed rule that would require Medicare Part
“Build Back Better” Bill Would Help Millions of People with Medicare Afford Medications
December 2, 2021
The Kaiser Family Foundation (KFF) recently released an issue brief detailing the prescription drug proposals in Build Back Better (BBB), the bill that
Medicare Rights Applauds Passage of the House Build Back Better Bill
November 24, 2021
This Thanksgiving, we are grateful to advocates like you, for your tireless work to improve policies, programs, and lives. The
Analysis Shows Benefits for People with Medicare in the Current “Build Back Better” Bill
November 18, 2021
As the “Build Back Better” (BBB) budget reconciliation bill begins its journey through Congress, the Kaiser Family Foundation (KFF) has
Further Evaluation of Potential Caps in Part D Shows Promise for Beneficiary Impact
April 14, 2022
A recently released report from the Urban Institute shows that a firm limit on out-of-pocket (OOP) Part D costs, like
New KFF Report Examines Beneficiary Exposure to Part B Drug Costs
March 17, 2022
A new brief from the Kaiser Family Foundation (KFF) examines the often extreme cost liability that Part B covered drugs—typically,
Drug Prices Already Rising in 2022
March 10, 2022
A new analysis from the AARP Public Policy Institute finds drug companies have increased prices for many brand name Part
Medicare Rights Supports Important Proposals for Medicare Advantage and Part D Plans
March 10, 2022
This week, Medicare Rights submitted comments on a proposed rule that would make some important changes to Medicare Advantage (MA)
Medicare Rights Joins 90 Organizations Urging Senate to Pass Drug Pricing Reforms
February 10, 2022
This week, over 90 advocacy and other organizations sent a letter to U.S. Senators, urging them to pass the drug
Letter to Senators Urging Drug Pricing Reform
February 9, 2022
Medicare Rights joined over 90 groups to urge US Senators to pass drug pricing reforms through reconciliation.
Proposed Rule Might Reduce Out-of-Pocket Drug Costs for Some People with Medicare
January 13, 2022
Last week, the Centers for Medicare & Medicaid Services (CMS) released a new proposed rule that would require Medicare Part
“Build Back Better” Bill Would Help Millions of People with Medicare Afford Medications
December 2, 2021
The Kaiser Family Foundation (KFF) recently released an issue brief detailing the prescription drug proposals in Build Back Better (BBB), the bill that
Medicare Rights Applauds Passage of the House Build Back Better Bill
November 24, 2021
This Thanksgiving, we are grateful to advocates like you, for your tireless work to improve policies, programs, and lives. The
Analysis Shows Benefits for People with Medicare in the Current “Build Back Better” Bill
November 18, 2021
As the “Build Back Better” (BBB) budget reconciliation bill begins its journey through Congress, the Kaiser Family Foundation (KFF) has